P. falciparum NF54 parasites (27 (link)) were grown in vitro in O Rh+ erythrocytes at 37°C in a controlled atmosphere, using complete culture medium (RPMI 1640 supplemented with 0.5% AlbuMax II [Life Technologies BV, Nærum, Denmark]), essentially as described previously (28 (link)). The P. falciparum NF54-derived and pVBH-transfected clone G6 was generated as described elsewhere (29 (link)– (link)31 (link)). It was maintained in the same way as the parental strain P. falciparum NF54, except that blasticidin (10 mg/ml; Life Technologies) was added to shut down transcription of endogenous var genes and to erase the epigenetic memory. IEs were selected for surface expression of defined PfEMP1 proteins by immunomagnetic selection using (i) PfEMP1-specific rat antisera followed by biotinylated anti-rat antibody (Dako) and streptavidin-coupled Dynabeads (Fisher Scientific) or (ii) PAM1.4 followed by protein A-coupled Dynabeads (Fisher Scientific), essentially as described previously (32 (link)). For selection of IgM-binding IEs, we used human IgM (Sigma) coupled to M-450 epoxy beads (Life Technologies) according to the manufacturers' instructions. The genotypic identity of the parasites and the absence of Mycoplasma contamination were verified regularly as described previously (33 (link)).